Physician profile
Simon J Hanft
NPI 1679732960
$93,155.96
in general payments reported to CMS, 2019-2025
11 companies · $24K in 2025
The $24K reported for 2025 was more than what 91% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.56 · 2020: $164 · 2021: $799 · 2022: $14K · 2023: $19K · 2024: $35K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $51K · Honoraria: $13K · Travel and Lodging: $8,272 · Food and Beverage: $5,726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $51,017.00 |
| Honoraria | $12,750.00 |
| Travel and Lodging | $8,271.70 |
| Food and Beverage | $5,726.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omniscient Neurotechnology America LTD | $45,375.16 | 2021-2025 | Quicktome |
| Gt Medical Technologies, INC | $44,913.02 | 2022-2025 | Gammatile, Gammatile |
| Zap Surgical Systems, INC. | $1,270.09 | 2021-2024 | Zap-X Mv Imager, Zap-X Treatment Delivery Software, Zap-X Radiosurgery System |
| Monteris Medical Corporation | $892.14 | 2021-2024 | Neuroblate |
| Medtronic, INC. | $415.09 | 2022-2023 | Activa PC |
| Baxter Healthcare | $180.01 | 2019-2020 | |
| Nuvasive, INC. | $27.63 | 2019 | |
| Medtronic USA, INC. | $23.94 | 2019 | |
| Orthofix Medical, INC. | $22.63 | 2022 | |
| Azurity Pharmaceuticals, INC. | $18.99 | 2023 | Gliadel |
| Stryker Corporation | $17.26 | 2024 | Universal Neuro 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Hanft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.